Global Cord Blood Corporation (CO) Tops Q2 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. ANET
6. DUOL
7. XYZ
8. SWKS
9. FISV
10. CVS

Go back to Global Cord Blood Corporation (CO) Tops Q2 EPS by 3c

Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2021

November 24, 2020 4:16 PM EST

HONG KONG, Nov. 24, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for the second quarter and first half of fiscal 2021 ended September 30, 2020.

Second Quarter of Fiscal 2021 Highlights

Revenues decreased by 8.9% year-over-year ("YoY") to RMB285.6 million ($42.1 million). New subscribers and accumulated subscriber base were 17,643 and 867,180[1], respectively. Gross profit decreased by 9.1% YoY to... More